Mutations in the HIV-1 reverse transcriptase tryptophan repeat motif affect virion maturation and Gag-Pol packaging

Virology

Volumn 422, Issue 2, 2012, Pages 278-287

  Chiang, Chien Cheng ^a   Tseng, Ying Tzu ^a   Huang, Kuo Jung ^a   Pan, Yen Yu ^a   Wang, Chin Tien ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Gag Pol packaging; HIV 1; PR mediated Gag processing; RT tryptophan repeat motif

Indexed keywords

EFAVIRENZ; GAG PROTEIN; POL PROTEIN; PROTEINASE; RNA DIRECTED DNA POLYMERASE;

ARTICLE; CONTROLLED STUDY; ENZYME DEGRADATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTASE TRYPTOPHAN REPEAT MOTIF; VIROGENESIS; VIRUS ASSEMBLY; VIRUS MUTATION;

AMINO ACID SUBSTITUTION; FUSION PROTEINS, GAG-POL; GENE EXPRESSION REGULATION, VIRAL; HEK293 CELLS; HELA CELLS; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; MUTATION; REPETITIVE SEQUENCES, AMINO ACID; TRYPTOPHAN; VIRION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84855195718     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.11.001     Document Type: Article

References (50)

1. Bacheler L.T., Anton E.D., Kudish P., Baker D., Bunville J., Krakowski K., Bolling L., Aujay M., Wang X.V., Ellis D., Becker M.F., Lasut A.L., George H.J., Spalding D.R., Hollis G., Abremski K. Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy. Antimicrob. Agents Chemother. 2000, 44(9):2475-2484.
2. Baillon J.G., Nashed N.T., Kumar A., Wilson S.H., Jerina D.M. A leucine zipper-like motif may mediate HIV reverse transcriptase subunit binding. New Biol. 1991, 3(10):1015-1019.
3. Bukovsky A., Gottlinger H. Lack of integrase can markedly affect human immunodeficiency virus type 1 particle production in the presence of an active viral protease. J. Virol. 1996, 70(10):6820-6825.
4. Buxton P., Tachedjian G., Mak J. Analysis of the contribution of reverse transcriptase and integrase proteins to retroviral RNA dimer conformation. J. Virol. 2005, 79(10):6338-6348.
5. Chang Y.-F., Wang S.-M., Huang K.-J., Wang C.-T. Mutations in capsid major homology region affect assembly and membrane affinity of HIV-1 Gag. J. Mol. Biol. 2007, 370(3):585-597.
6. Chen S.-W., Chiu H.-C., Liao W.-H., Wang F.-D., Chen S.S.L., Wang C.-T. The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles. Virology 2004, 318(2):534-541.
7. Chiang C.-C., Wang S.-M., Pan Y.-Y., Huang K.-J., Wang C.-T. A single amino acid substitution in HIV-1 reverse transcriptase significantly reduces virion release. J. Virol. 2010, 84(2):976-982.
8. Chiang C.-C., Wang S.-M., Tseng Y.-T., Huang K.-J., Wang C.-T. Mutations at human immunodeficiency virus type 1 reverse transcriptase tryptophan repeat motif attenuate the inhibitory effect of efavirenz on virus production. Virology 2009, 383(2):261-270.
9. Chien A.I., Liao W.H., Yang D.M., Wang C.T. A domain directly C-terminal to the major homology region of human immunodeficiency type 1 capsid protein plays a crucial role in directing both virus assembly and incorporation of Gag-Pol. Virology 2006, 348(1):84-95.
10. Chiu H.C., Yao S.Y., Wang C.T. Coding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160(gag-pol) into virus particles. J. Virol. 2002, 76(7):3221-3231.
11. di Marzo Veronese F., Copeland T.D., DeVico A.L., Rahman R., Oroszlan S., Gallo R.C., Sarngadharan M.G. Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science 1986, 231(4743):1289-1291.
12. Dougherty D.A. Cation-{pi} interactions involving aromatic amino acids. J. Nutr. 2007, 137(6):1504S-1508S.
13. Dunn L.L., McWilliams M.J., Das K., Arnold E., Hughes S.H. Mutations in the thumb allow human immunodeficiency virus Type 1 reverse transcriptase to be cleaved by protease in virions. J. Virol. 2009, 83(23):12336-12344.
14. Ferris A.L., Hizi A., Showalter S.D., Pichuantes S., Babe L., Craik C.S., Hughes S.H. Immunologic and proteolytic analysis of HIV-1 reverse transcriptase structure. Virology 1990, 175(2):456-464.
15. Figueiredo A., Moore K.L., Mak J., Sluis-Cremer N., de Bethune M.-P., Tachedjian G. Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol. PLoS Pathog. 2006, 2(11):e119.
16. Ghosh M., Jacques P.S., Rodgers D.W., Ottman M., Darlix J.L., Le Grice S.F.J. Alterations to the primer grip of p66 HIV-1 reverse transcriptase and their consequences for template-primer utilization. Biochemistry 1996, 35(26):8553-8562.
17. Goel R., Beard W.A., Kumar A., Casas-Finet J.R., Strub M.P., Stahl S.J., Lewis M.S., Bebenek K., Becerra S.P. Structure/function studies of HIV-1 reverse transcriptase: dimerization-defective mutant L289K. Biochemistry 1993, 32(48):13012-13018.
18. Gottlinger H.G., Sodroski J.G., Haseltine W.A. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 1989, 86(15):5781-5785.
19. Graham R., van der Eb A. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973, 52:456-467.
20. Grandgenett D.P., Goodarzi G. Folding of the multidomain human immunodeficiency virus type-I integrase. Protein Sci. 1994, 3(6):888-897.
21. Halwani R., Khorchid A., Cen S., Kleiman L. Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus Type 1. J. Virol. 2003, 77(7):3973-3984.
22. Hizi A., McGill C., Hughes S.H. Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants. Proc. Natl. Acad. Sci. 1988, 85(4):1218-1222.
23. Huang M., Martin M.A. Incorporation of Pr160(gag-pol) into virus particles requires the presence of both the major homology region and adjacent C-terminal capsid sequences within the Gag-Pol polyprotein. J. Virol. 1997, 71(6):4472-4478.
24. Huang W., Gamarnik A., Limoli K., Petropoulos C.J., Whitcomb J.M. Amino acid substitutions at position 190 of human immunodeficiency virus Type 1 reverse transcriptase increase susceptibility to delavirdine and impair virus replication. J. Virol. 2003, 77(2):1512-1523.
25. Jacks T., Power M.D., Masiarz F.R., Luciw P.A., Barr P.J., Varmus H.E. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature 1988, 331(6153):280-283.
26. Kay B.K., Williamson M.P., Sudol M. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J. 2000, 14(2):231-241.
27. Kohl N.E., Emini E.A., Schleif W.A., Davis L.J., Heimbach J.C., Dixon R.A., Scolnick E.M., Sigal I.S. Active human immunodeficiency virus protease is required for viral infectivity. Proc. Natl. Acad. Sci. U.S.A. 1988, 85(13):4686-4690.
28. Liao W.-H., Huang K.-J., Chang Y.-F., Wang S.-M., Tseng Y.-T., Chiang C.-C., Wang J.-J., Wang C.-T. Incorporation of human immunodeficiency virus Type 1 reverse transcriptase into virus-like particles. J. Virol. 2007, 81(10):5155-5165.
29. Liao W.-H., Wang C.-T. Characterization of human immunodeficiency virus type 1 Pr160gag-pol mutants with truncations downstream of the protease domain. Virology 2004, 329(1):180-188.
30. Lightfoote M.M., Coligan J.E., Folks T.M., Fauci A.S., Martin M.A., Venkatesan S. Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus. J. Virol. 1986, 60(2):771-775.
31. Mulky A., Sarafianos S.G., Jia Y., Arnold E., Kappes J.C. Identification of amino acid residues in the human immunodeficiency virus Type-1 reverse transcriptase tryptophan-repeat motif that are required for subunit interaction using infectious virions. J. Mol. Biol. 2005, 349(4):673-684.
32. Olivares I., Mulky A., Boross P.I., Tozser J., Kappes J.C., Lopez-Galindez C., Menendez-Arias L. HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions. J. Mol. Biol. 2007, 372(2):369-381.
33. Page K.A., Landau N.R., Littman D.R. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 1990, 64(11):5270-5276.
34. Peng C., Ho B.K., Chang T.W., Chang N.T. Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity. J. Virol. 1989, 63(6):2550-2556.
35. Quillent C., Borman A.M., Paulous S., Dauguet C., Clavel F. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation. Virology 1996, 219(1):29-36.
36. Ratner L., Haseltine W., Patarca R., Livak K.J., Starcich B., Josephs S.F., Doran E.R., Rafalski J.A., Whitehorn E.A., Baumeister K., et al. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 1985, 313(6000):277-284.
37. Simon S., Krejci E., Massoulie J. A four-to-one association between peptide motifs: four C-terminal domains from cholinesterase assemble with one proline-rich attachment domain (PRAD) in the secretory pathway. EMBO J. 1998, 17(21):6178-6187.
38. Smith A.J., Srinivasakumar N., Hammarskjold M.L., Rekosh D. Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles. J. Virol. 1993, 67(4):2266-2275.
39. Srinivasakumar N., Hammarskjold M.L., Rekosh D. Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation. J. Virol. 1995, 69(10):6106-6114.
40. Swanstrom R., Wills J. Synthesis, assembly and processing of viral proteins. Retroviruses 1997, 263-334. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. J. Coffin, S. Hughes, H. Varmus (Eds.).
41. Tachedjian G., Aronson H.-E.G., Goff S.P. Analysis of mutations and suppressors affecting interactions between the subunits of the HIV type 1 reverse transcriptase. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(12):6334-6339.
42. Tachedjian G., Aronson H.-E.G., Santos M.d.l., Seehra J., McCoy J.M., Goff S.P. Role of residues in the tryptophan repeat motif for HIV-1 reverse transcriptase dimerization. J. Mol. Biol. 2003, 326(2):381-396.
43. Tachedjian G., Moore K.L., Goff S.P., Sluis-Cremer N. Efavirenz enhances the proteolytic processing of an HIV-1 pol polyprotein precursor and reverse transcriptase homodimer formation. FEBS Lett. 2005, 579(2):379-384.
44. Tachedjian G., Orlova M., Sarafianos S.G., Arnold E., Goff S.P. Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptase. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(13):7188-7193.
45. Venezia C.F., Howard K.J., Ignatov M.E., Holladay L.A., Barkley M.D. Effects of Efavirenz binding on the subunit equilibria of HIV-1 reverse transcriptase. Biochemistry 2006, 45(9):2779-2789.
46. Wapling J., Moore K.L., Sonza S., Mak J., Tachedjian G. Mutations that abrogate human immunodeficiency virus Type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer. J. Virol. 2005, 79(16):10247-10257.
47. Wohrl B.M., Krebs R., Thrall S.H., Le Grice S.F., Scheidig A.J., Goody R.S. Kinetic analysis of four HIV-1 reverse transcriptase enzymes mutated in the primer grip region of p66, implications for DNA synthesis and dimerization. J. Biol. Chem. 1997, 272(28):17581-17587.
48. Yee J.K., Friedmann T., Burns J.C. Generation of high-titer pseudotyped retrovirus with very broad host range. Methods Cell Biol. 1994, 43:99-112.
49. Yu Q., Ottmann M., Pechoux C., Le Grice S., Darlix J.L. Mutations in the primer grip of human immunodeficiency virus type 1 reverse transcriptase impair proviral DNA synthesis and virion maturation. J. Virol. 1998, 72(9):7676-7680.
50. Zybarth G., Carter C. Domains upstream of the protease (PR) in human immunodeficiency virus type 1 Gag-Pol influence PR autoprocessing. J. Virol. 1995, 69(6):3878-3884.